Phase II study of gemcitabine in ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/10/7/853/19477815/10-7-853.pdf
Reference5 articles.
1. Gemcitabine in cisplatin-resistant ovarian cancer;Lund;Semin Oncol,1996
2. The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology;Aaronson;J Natl Cancer Inst,1993
3. A phase II study of gemcitabine in platinum pretreated patients with advanced epithelial ovarian cancer;Friedlander;Ann Oncol,1998
4. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer;Ten Bokkel Huinink;J Clin Oncol,1997
5. Activity of gemcitabine in patients with advanced ovarian cancer: Responses seen following platinum and paclitaxel;Shapiro;Gynecol Oncol,1996
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial;Journal of Gynecologic Oncology;2021
2. Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study;Minerva Ginecologica;2019-05
3. A phase I pharmacokinetic and pharmacodynamic study of GTI-2040 in combination with gemcitabine in patients with solid tumors;Cancer Chemotherapy and Pharmacology;2018-07-18
4. Gemcitabine induces apoptosis and autophagy via the AMPK/mTOR signaling pathway in pancreatic cancer cells;Biotechnology and Applied Biochemistry;2018-04-16
5. The potential of radiolabeled chemotherapeutics in tumor diagnosis: Preliminary investigations with68Ga-gemcitabine;Drug Development Research;2018-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3